Tradestie Institutional Equity Comparison Engine

AACB vs VACH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-08-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AACB Overall Edge

AACB Captures Institutional Edge (1โ€“1 Pillars ยท 4โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AACB (AACB) driven by superior Valuation while VACH counters with relative strength in Momentum & Technical. Fundamentally, AACB trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VACH at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AACB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VACH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AACB
AACB N/M vs VACH N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner VACH
1Y +5.5% vs +65.7% ยท 52W Pos 98% vs 89%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AACB US Equity
AACB
Institutional Equity
$10.59
+0.09% 1D
Market Cap $292.8M
1M Return +0.86%
1Y Return +5.48%
Forward P/E N/M
Unified AI Score
55.3 / 100 HOLD
Tech 44.0 Fund 52.0 Flow 50.0 Mom 70.0
VACH NASDAQ
Voyager Acquisition Corp Class A Ordinary Shares
Biological Products, (No Disgnostic Substances)
$17.11
-1.07% 1D
Market Cap $547.1M
1M Return +35.72%
1Y Return +65.68%
Forward P/E N/M
Unified AI Score
51.6 / 100 HOLD
Tech 45.0 Fund 47.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AACB +5.48% VACH +65.68% Spread: +61.72 pp (VACH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AACB TTM Op. Margin: 0.0% VACH TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AACB vs VACH. Trailing 12-month operating profitability (AACB 0.0% vs VACH 0.0%) and valuation multiples (AACB N/M vs VACH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AACB (4) vs VACH (1)
Institutional Metric AACB VACH Criterion Row Winner
Market Capitalization Scale $292.8M $547.1M Larger Scale VACH
Trailing P/E Ratio Valuation 62.2x 82.4x Lower Multiple AACB
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency 0.0% 0.0% Higher ROE Tie
52-Week Range Position Momentum 98% ($10โ€“$11) 89% ($8โ€“$18) Stronger Trend AACB
Beta / 30D Volatility Risk Regime 0.02ฮฒ ยท 3% Vol 0.08ฮฒ ยท 180% Vol Lower Realized Risk AACB
Unified Institutional Score Composite Signal 55.3 / 100 (HOLD) 51.6 / 100 (HOLD) Higher Composite AACB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AACB vs VACH Buy Guide
AACB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AACB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VACH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VACH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AACB nor VACH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.